Investors should look beyond the headline but be aware of the bigger implications

What are Negative Oil Prices Telling us about the Future for Energy Companies?

(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)

On Monday, the May oil contract for West Texas Intermediate (WTI) oil turned negative for the first time ever. WTI futures, which expire on Tuesday, settled at $(37.63) on Monday before climbing back to positive on Tuesday. Negative prices reflect the fact that producers are willing to pay consumers for May delivery under fear that storage will run out by the end of May. WTI pricing is for delivery at Cushing, Oklahoma. Last week, the Energy Information Administration (EIA) reported that storage facilities at Cushing, Oklahoma were 72% full as of April 10. So, are negative oil prices a temporary fluke caused by unusual circumstances, or is it a harbinger of bigger problems to come?

Reasons to Not Be Concerned

WTI is not a good measure of the value of oil. WTI pricing is the most common reference for North American producers. It is, however, not the only reflection of the value of oil. International producers often refer to Brent oil prices, which measures oil prices in the North Sea, as a more relevant price. Brent oil prices closed Monday above $20 per barrel before dipping into the high teens on Tuesday. WTI pricing is complicated by the fact that the pricing point is land locked. Oil has nowhere to go if storage is full given pipeline constraints between Cushing and Henry Hub that have developed due to increased Permian oil production. North Sea oil, on the other hand, can head to many different ports or even stay on tankers if needed.

It’s the May contract only. It is worth noting that while the May futures contact turned negative, the June contract remained near $20 per barrel on Monday before settling at $11.57 on Tuesday.  This is not necessarily a reflection that traders believe the supply demand situation will improve in 30 days but more a representation that the issues facing the May contract are storage related. May contract issues are worsened by the fact that May is a shoulder month for oil demand -after the winter heating season but before the summer driving season. The EIA typically reports a peak oil storage date in the middle of May.

A demand response is coming. President Trump announced plans to buy 75 million barrels of oil to place into the nation’s strategic reserve. The purchase would move the strategic reserve from 80% full to 89% full (total reserve capacity is 797 million barrels). The purchase represents approximately 1 day of world oil demand. As such, the move, while positive, is unlikely to sop up much of the excess supply, and it will be unable to be repeated. Of bigger importance is when the economy will start to rebound as virus preventions are eased.

The supply response is coming. Opec Plus agreed to cut 9.7 million barrels of daily oil production beginning in May. Further cuts are possible should oil prices remain at depressed levels. Of course, this will not help domestic oil production facing limited storage options but should help the overall equation. We suspect that domestic oil producers have all but cancelled plans for future drilling. This will lower supply but may take a year or so to have an impact. A more immediate drop in supply would come if producers began shutting in production from existing wells. Texland Petroeum LP announced the shut in of its 1,211 oil wells on April 13. ConocoPhillips announced the shut in of 125,000 barrels of oil per day in Canada on April 20th. Other smaller producers have followed suit.  Jeffrey Currie, head of commodities at Goldman Sachs, estimates that one million barrels of oil per day has been shut down.

Concern for Oil & Oil Service

Negative prices reflect a drop in demand. A study by HIS Markit estimates that world oil consumption has declined 25 million barrels per day, or approximately 25%. The 9.7 million BBL/day production cut by OPEC Plus was impressive but offsets less than 40% of the drop in demand. 

OPEC Plus still has incentives to cheat. OPEC has a history of agreeing to production decreases and then not living up to agreed levels. Countries facing economic hardships will certainly have an incentive to produce above their set level. 

Production costs continue to decline. Rig rates and other costs are falling as oil service companies compete to create revenues. Energy companies that are still drilling are focused on their top drilling prospects, which have the lowest costs. The results could mean oil prices remain low until there are signs that demand has returned.

Summary

Negative oil prices make good headline news. Investors should keep in mind that a negative oil price for the May WTI contract is not indicative of the value of oil. Other contacts for different delivery dates or locations have not suffered the same effect as the May WTI contract. Instead, negative prices reflect short-term issues associated with storage at a difficult time of the year for oil prices. That said, the glut of oil clearly reflects a sharp drop in demand due to attempts to control the spread of the coronavirus. A supply response; whether it be from OPEC Plus, decreased domestic drilling or the shut in of existing production, is coming but will take months if not years to offset the drop in demand. 

Suggested Content:

Energy
Sector Review – April 2020

inPlay
Oil – Models Updated for Lower Oil Prices April 2020

Crisis
in the Oval Office

 

Sources:

https://www.barrons.com/articles/oil-stocks-producers-negatve-futures-prices-contract-barrels-51587414871?siteid=yhoof2&yptr=yahoo, Avi Salzman, Barrons, April 20, 2020

https://www.theweek.in/news/world/2020/04/21/explainer-oil-prices-negative-us-wti-what-does-it-mean-consumers-pump-gas-prices.html, The Week, April 21, 2020

https://www.texastribune.org/2020/04/06/texas-oil-producers-shutting-wells-coronavirus-dispute-plummet-prices/, Mitchell Ferman, The Texas Tribune, April 6, 2020

https://www.axios.com/coronavirus-oil-oversupply-ad858690-cce4-4768-8d28-4165349c2624.html, AXIOS, April 13, 2020

Research energy services of america esoa positive developments amidst covid 19 uncertainty

Thursday, April 23, 2020

Energy Services of America (ESOA)

Positive Developments Amidst COVID-19 Uncertainty

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is primarily engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical and automotive industries, and does incidental work such as water and sewer projects. Energy Service’s other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services and other services related to pipeline construction.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    New addition to management. Charles Austin was recently appointed as President of C.J. Hughes, the largest subsidiary. With 40 years of experience in the natural gas and underground utility industries, including 19 years previously with C.J. Hughes, Mr. Austin adds depth to the management team. Doug Reynolds remains President of Energy Services.

    Maintaining FY2020 EBITDA of $7.1 million and Treasury PPP program accessed.  Forecasted revenue is $110.1 million, with gross margin of 10.6% and EBITDA margin of 6.4%. Energy Services applied for and received ~ $12.5 million from the Paycheck Protection Program (PPP) established by the Department of Treasury to help smaller companies retain…



    Click here to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research great panther mining limited gpl new leadership takes the field

Wednesday, April 22, 2020

Great Panther Mining Limited (GPL)

New Leadership Takes the Field

Great Panther Mining Limited, headquartered in Vancouver, Canada, is a precious metals mining and exploration company that operates three mines. These include: 1) the Tucano gold mine in Amapa State, Brazil, 2) the Guanajuato mine complex which includes the Guanajuato and San Ignacio mines in Mexico, and 3) the Topia mine in Mexico. Great Panther also owns the Coricancha Mine in Peru, which is expected to restart operations in 2020. The shares are traded under the ticker “GPR” on the Toronto Stock Exchange and under the ticker “GPL” on the NYSE American.

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Executive Appointments. Mr. Rob Henderson has been appointed President and CEO effective April 21. Previously, Mr. Henderson served as President and CEO of Amerigo Resources Ltd., a copper producer with assets in Chile. Additionally, Ms. Meghan Brown joined the company as Vice President, Investor Relations. Ms. Brown served as Vice President, Investor Relations at Leagold Mining Corporation until its March 2020 merger with Equinox Gold.

    Three new board members. Effective immediately, the Board appointed Mr. David Garofalo as Chair. Mr. Garofalo was President and CEO of Goldcorp Inc. until its sale to Newmont Corporation in April 2019. Additionally, Mr. Joseph Gallucci and Mr. Alan Hair joined the board of directors. Mr. Jeffrey Mason, previous Chair and interim CEO, will provide consulting services to facilitate the transition of executive responsibilities. Mr. Robert Archer will not stand for re-election to the Board at the 2020 Annual General Meeting but will continue to…


    Click here to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

What Now? Post-Pandemic Stock Market Investing

Your Move – Three Investment Ideas to Consider Now

(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)

Stock market indices have gained a large portion of their value back after having been down as much as 34% over the past month. The major market averages are now off their high less than 20%. The unpredictable massive rally in these benchmarks included record moves that will surely be studied in history books – as will the selloff that took place the month earlier. 

The magnitude of this upward index bounce is very misleading. Have you noticed that most sectors have not participated in any meaningful way? In fact, some of the more deflated stocks are still near their lows, others have fallen further. Here’s why.

Stocks With
the Most Pull

“The top five companies in the
S&P 500 have never occupied a greater share of the benchmark’s total market
capitalization.”
 – Mike Bird, WSJ, April 20, 2020

Companies that have added the most to the rise of the Nasdaq and S&P 500 over the past month are tech giants such as Amazon, Intel, and Microsoft. Today, just five stocks MSFT, AAPL, FB, GOOG, and GOOGL account for 20% of the market cap for the entire S&P 500. That exceeds their concentration during the dotcom bubble of 2000.  The entire IT sector now accounts for a 25.4% weighting in the S&P 500 (a/o 4/17/20). None of the other ten major sectors even come close. While technology, which does not have a reputation of being defensive, has contributed most to index returns, some other individual companies have also held up well, especially in healthcare and consumer staples two more traditional defensive sectors.

 

Reuters Graphic

The performance of the entire S&P is in
large part because of participation by a few stocks.

Where Do We Go From Here

The market seems to be past the “blood in the streets” stage, where investors were tripping over themselves to unload stocks indiscriminately. The extreme rise in the tech sector looks to have been the standard kneejerk reaction by speculators trying to get in early and by those that followed the move and chased stocks behind them. The next move, if the worst is behind us, is typically more rational. That soberness may carry the overall market sideways to down as some participants wait for confirmation that indeed the economic road ahead will be positive.

While the overall indices may simmer, this will likely be because of cooling of the tech stocks while more traditional plays begin to heat up.

Strategies
for Low-Risk Exposure

The crisis fell upon us fast, but we learn fast. The follow-up in the investment markets is likely to be quick. In the same way, everyone quickly learned how to put on a mask, have Zoom meetings, and food shop for longer than a week at a time; investors are going to become more adept at crisis investing.

In the past, crisis investment strategies have always had three strong tenets:

1). Be very selective (not major market investing)

2). Be more defensive (base decisions on worst-case scenario)

3). Be among the first (don’t chase)  

The best risk/return opportunities for investors will likely present themselves from long-term secular trends. The pandemic and the coinciding stay-at-home policies have accelerated many of these trends in tech usage. Look to capitalize on the old strong sectors that could experience a tailwind from the revised world we’re entering.

The old trends that had been worth watching in stocks, that will be enhanced once most of the economic lights are turned back on, include; a world that is more digital, a world that is more in debt and a world that values medical miracles.  

Three
Investment Areas that Should get Warmer

1). Stable and
defensive stocks
– This may seem obvious, but many people still get caught up in “sexy” stocks and chasing what is most highlighted on CNBC or Fox Business News. Invest in stocks that display earnings growth trends that are less likely to be negatively impacted by “sheltering in place.”  Many people saw the TP shortage as an inconvenience; investors should have researched it as an opportunity. Consumer staples and healthcare products are always in demand without regard to economic conditions. This places them on stable ground for a defensive position. In many cases, the increased hours people stay at home has placed further demand on items such as soap, and paper products, while possibly lowering demand for items like hair gel and deodorant. This is why specific companies, rather than a consumer goods ETF, is preferable.

Many of these stocks pay dividends. This not only adds to return, it helps make the equities more attractive as yield investors are bumping up against sub 1% government bond rates. Dividends cause the stocks to be less volatile overall.

2). Cyclical stocks– Ahead of a firm-footed recovery, selective investing in cyclical companies that thrive as people open up their wallets, may look different than in the past. Discretionary spending will likely increase in areas that have pent-up demand. These could include household appliances, recreation, online dating, fitness, etc..

3). Long-term trends- We’ve already had a taste of the accelerated structural changes that could define this decade. There has been a digital transformation. This has set much deeper roots in the past month than it has in the past three years. The momentum is not likely to slow. Technological disruptors that improve work and home life seem to be in a position to maintain their above-average growth. Any dip in stock prices allows entry at a reasonable level as renewed activity should once again prove rewarding longer term. E-Commerce also got a boost from the lockdown’s effect on brick and mortar stores. The boost in popularity is likely to stick at a higher level than pre-crisis, thus providing a new base for these products.

Pharmaceutical and biotech companies with pipelines for drug and genetic therapies will continue to garner attention as the population has the pandemic fresh on their mind and now shows increased support for more rapid discovery, clinical trials, and FDA review.

Take-Away

The bounce that we have seen in the major indices is not representative of the movement in the various components of the underlying index. The split or bifurcation likely has sectors overbought while others that should get attention have been overshadowed by these “stars.” The coming recovery is likely to unfold slow but sure. Focusing on the surest beneficiaries of the eventual recovery is less speculative and more prudent. Chasing relatively high-flyers, or owning them by default because you have invested in an index fund may be less profitable. There is still much uncertainty moving forward. Picking your short, medium, and long term positions with more rationally will allow participation in moves upward with comfortable risk-adjusted returns in volatile times.

Suggested Reading:

Why
Index funds Could Be a Mistake in 2020

Stock
Index adjustments and Self-Directed Investing

Additional
Balance in 60/40 Asset Mixes

Sources:

The
Winner Takes All Stock Market Rally

Titans
Dominate Stock market

Twitter- @Birdyword

Research – One Stop Systems Inc. (OSS) – Completes $6 Million Convertible Note Raise

Wednesday, April 22, 2020

One Stop Systems Inc. (OSS)

Completes $6 Million Convertible Note Raise

One Stop Systems Inc is US-based company which is principally engaged in designing, manufacturing, marketing high-end systems for high performance computing (HPC) applications. The company offers custom servers, compute accelerators, solid-state storage arrays and system expansion systems. The product line of the company includes GPU Appliances, GPU Expansion, GPUs and co-processors, Flash storage arrays, Flash storage expansion, Servers, Disk Arrays, Desktop computing appliances, accessories and parts. The company delivers high-end technology to customers through the sale of equipment and software for use on their premises or through remote cloud access to secure data centres housing technology.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Raise. As expected, One Stop completed the previously announced $6 million senior secured convertible note raise. The raise provides OSS with additional flexibility in these challenging times. In addition to this raise, the Company has applied for government assistance under both the PPP and the Disaster Recovery programs.

    Terms. At initial close, OSS will issues $3 million of Notes to the buyers at a 10% OID. The notes do not bear interest, unless the Company goes into default, at which time the interest rate would be 18%. The notes have a fixed conversion price of $2.50 for the first six months, a premium above the closing price of the Company’s common stock on Monday, April 20, 2020, after which time the fixed conversion price may reset to…


    Click here to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research one stop systems inc- oss completes 6 million convertible note raise

Wednesday, April 22, 2020

One Stop Systems Inc. (OSS)

Completes $6 Million Convertible Note Raise

One Stop Systems Inc is US-based company which is principally engaged in designing, manufacturing, marketing high-end systems for high performance computing (HPC) applications. The company offers custom servers, compute accelerators, solid-state storage arrays and system expansion systems. The product line of the company includes GPU Appliances, GPU Expansion, GPUs and co-processors, Flash storage arrays, Flash storage expansion, Servers, Disk Arrays, Desktop computing appliances, accessories and parts. The company delivers high-end technology to customers through the sale of equipment and software for use on their premises or through remote cloud access to secure data centres housing technology.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Raise. As expected, One Stop completed the previously announced $6 million senior secured convertible note raise. The raise provides OSS with additional flexibility in these challenging times. In addition to this raise, the Company has applied for government assistance under both the PPP and the Disaster Recovery programs.

    Terms. At initial close, OSS will issues $3 million of Notes to the buyers at a 10% OID. The notes do not bear interest, unless the Company goes into default, at which time the interest rate would be 18%. The notes have a fixed conversion price of $2.50 for the first six months, a premium above the closing price of the Company’s common stock on Monday, April 20, 2020, after which time the fixed conversion price may reset to…


    Click here to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – Great Panther Mining Limited (GPL) – New Leadership Takes the Field

Wednesday, April 22, 2020

Great Panther Mining Limited (GPL)

New Leadership Takes the Field

Great Panther Mining Limited, headquartered in Vancouver, Canada, is a precious metals mining and exploration company that operates three mines. These include: 1) the Tucano gold mine in Amapa State, Brazil, 2) the Guanajuato mine complex which includes the Guanajuato and San Ignacio mines in Mexico, and 3) the Topia mine in Mexico. Great Panther also owns the Coricancha Mine in Peru, which is expected to restart operations in 2020. The shares are traded under the ticker “GPR” on the Toronto Stock Exchange and under the ticker “GPL” on the NYSE American.

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Executive Appointments. Mr. Rob Henderson has been appointed President and CEO effective April 21. Previously, Mr. Henderson served as President and CEO of Amerigo Resources Ltd., a copper producer with assets in Chile. Additionally, Ms. Meghan Brown joined the company as Vice President, Investor Relations. Ms. Brown served as Vice President, Investor Relations at Leagold Mining Corporation until its March 2020 merger with Equinox Gold.

    Three new board members. Effective immediately, the Board appointed Mr. David Garofalo as Chair. Mr. Garofalo was President and CEO of Goldcorp Inc. until its sale to Newmont Corporation in April 2019. Additionally, Mr. Joseph Gallucci and Mr. Alan Hair joined the board of directors. Mr. Jeffrey Mason, previous Chair and interim CEO, will provide consulting services to facilitate the transition of executive responsibilities. Mr. Robert Archer will not stand for re-election to the Board at the 2020 Annual General Meeting but will continue to…


    Click here to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research pds biotechnology corp pdsb expanding product pipeline into infectious diseases

Tuesday, April 21, 2020

PDS Biotechnology Corp (PDSB)

Expanding Product Pipeline into Infectious Diseases

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Cosme Ordonez, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Versamune is a versatile platform technology. Versamune is a versatile platform technology. PDS Biotechnology, Corp. is developing a platform technology known as Versamune, which consists of lipid nanoparticles designed to deliver disease-specific antigens to stimulate a potent immune response. Versamune has potential applications for the treatment of cancer and infectious diseases. The Company’s lead product PDS0101 is being developed for the treatment of HPV-associated cancers.

PDS is expanding its product pipeline. PDS has recently announced the commencement of programs to develop vaccines targeting COVID-19 and influenza. At present, the Company has three new programs in infectious diseases with one therapeutic vaccine PDS0201 against tuberculosis and two preventive vaccines, PDS0203/PDS0202, in development for COVID-19 and…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – PDS Biotechnology Corp (PDSB) – Expanding Product Pipeline into Infectious Diseases

Tuesday, April 21, 2020

PDS Biotechnology Corp (PDSB)

Expanding Product Pipeline into Infectious Diseases

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Cosme Ordonez, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Versamune is a versatile platform technology. Versamune is a versatile platform technology. PDS Biotechnology, Corp. is developing a platform technology known as Versamune, which consists of lipid nanoparticles designed to deliver disease-specific antigens to stimulate a potent immune response. Versamune has potential applications for the treatment of cancer and infectious diseases. The Company’s lead product PDS0101 is being developed for the treatment of HPV-associated cancers.

PDS is expanding its product pipeline. PDS has recently announced the commencement of programs to develop vaccines targeting COVID-19 and influenza. At present, the Company has three new programs in infectious diseases with one therapeutic vaccine PDS0201 against tuberculosis and two preventive vaccines, PDS0203/PDS0202, in development for COVID-19 and…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Why Index Funds Could be a Mistake in 2020

The 2020 Investment Buzzword No one is Using Yet!

(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)

Today when investors say they are “in the market” or “out of the market,” they most often are using shorthand to discuss the stock market. This is understood, even though there are many other active investment markets.  The others don’t get as much attention. In fact, because of current investment practices, the term “in the market” usually implies exposure to one of the major index averages.

It wasn’t always this way. Not too long ago, investors would build a portfolio working with a broker and buy a small basket of stocks. Commissions were high, but a good broker was worth the price because of the in-depth research they conducted. Back then, “in the market” didn’t mean broad exposure to 500-2000 holdings.  Far fewer. The reason for the change, of course, is an evolution that gained momentum around 1980. It was then that mutual funds started to become understood throughout households, many of which had never been “in the market” before.  Mutual funds allowed investors, even small ones, to benefit from what has been a cyclical but rising market, but with much lower entry fees.

The combination of the ease with which large mutual funds allowed an investor to gain or reduce exposure to equities, the comfort of being extremely diversified, the rising trend in stock prices, and the painless built-in fee made mutual funds an easy sell for fund companies.

Once invested, to determine if the fund manager was doing a good job, marketers began benchmarking their funds against major market indexes on the futures exchange (Dow, S&P, and later Russell). Investors were taught that good returns were “index” returns. Investors began to measure if their fund performed satisfactorily by how it stacked up against a broad index.  When this became the standard by which investors measured success, mutual fund companies created index funds with the objective of meeting or beating a specific index. Here is where they ran into some problems.

Matching an index, which has no fees, no slippage, and no flow of assets in or out (often at the worst times), is mathematically impossible for a fund manager without taking on additional risk. Index mutual funds often fell short of their benchmark. It wasn’t their fault. When markets are rising, investors put money into the fund, this adds to the average price of the underlying holdings. When markets fall abruptly, investors often pull money out. This locks in lower performance and prevents the fund manager from buying at lower prices. Also, managing fund flows requires a cash position; this dampens fund performance. Innovative financial engineers then addressed the issues and came up with a product that was more capable of tracking a major index return. The product was exchange-traded funds, and these became more popular to people whose goal was “market” returns.

Lower Cost Options

With the goal of index investing and tracking much closer to index returns,  exchange-traded funds (ETFs) made their debut in early 1993. State Street Global Advisors created the first which was the S&P 500 Trust (SPDR). This new fund type had lower fees and held a set amount of the underlying stocks. As a result, the fund trades virtually tick for tick with the S&P 500 index. SPDR gained popularity very quickly and is still the most actively traded ETF. Investment advisors have been able to lower the cost to their index fund invested clients as they moved them into this new innovation.  

Today there are ETFs that cover all the major indexes. What’s better is they now also cover all the underlying sectors within an index. So if you don’t like Financials but feel Energy is undervalued, you are no longer limited to just receiving broad index returns. You can pick and choose the categories within the equity markets and focus more heavily on one sector over another.  Building a custom portfolio using indexed sectors has become a more refined way to give investors above-average potential.

Sector Bifurcation

Market sector movement at the start of 2020 is a solid example why those that maintain an active investment portfolio should do more than just sit idle with broad market index funds.

The graphic below demonstrates how the Spyder defined sectors deviate drastically from each other. The economy is going through a period where the markets are bifurcated. There are sectors that are strong and rising while there are sectors that are weak and sinking. This is different from recent experiences where we saw all sectors generally moving in the same upward direction. The markets are likely to remain bifurcated and volatile until the pandemic crisis is history.

For investors looking to “pick their spots” in what is a more difficult market, they now have the ability to target sectors they deem superior and avoid those with low probability of satisfaction. The six-month chart below (Red is S&P 500, SPDR) shows that back in November Healthcare began outperforming the major index while Energy was falling off quite a bit. That trend continued and accelerated during the pandemic. Investors in the Healthcare ETF are up 10% over the past six months, Energy sector investors are down over 40%.

 

 

A close up of a map

Description automatically generated

Investors should consider a bias in their holding toward sectors with a more positive outlook and away from those with more negative using targeted ETFs.

Further Bifurcation

Within investment categories, especially during the current crisis, there is further bifurcation. Investing strictly in ETFs, even sector ETFs,  means still accepting the bad with the good. The pandemic has clearly altered the direction of individual company earnings. Sector funds don’t take this into account. Here is an extreme example:  Midway through last quarter investors began to flee from the category of hospitality. This was wise, the sector includes hotels, travel, restaurants, and event services. Poor performance within this sector was all but guaranteed.

A close up of a map

Description automatically generated

Avoiding an ETF focused on hospitality certainly turned out wise as forecasted. But what was also easy to forecast is that within the sector there would be opportunities in meal-kit companies like Blue Apron (APRN). The conclusion from this is, not only should investors no-longer just “buy the market” they should not just buy sector funds either. Having a core in the broader market is fine, weighing that more heavily with some sector funds is also good, but stock-picking is becoming more important than ever.

 

A close up of a map

Description automatically generated

Here’s another example, Energy was one of the worst beaten down sectors. Even within the energy sector there were huge gains to be found in companies like COG. Fortunately, investing in individual positions is no longer as expensive per transaction. Picking targeted companies makes more sense than ever.

ETF investing is still a low-cost way for a small investor to benefit from overall market growth without experiencing brokerage fees cutting into their results. They have had their reign and are now just another option to keep in the mix. This has become extremely apparent over the past few weeks, and it appears it will be an issue for a while. Investors may now be entering a new investment cycle where a wider variety of vehicles are implemented.

Just like with other cycles, we seem to be moving back toward where we started, individual stocks.

Finding Opportunity

Looking back since the beginning of the year and looking forward to the foreseeable future, we are seeing some sectors of the market doing substantially better than others. The market is bifurcated and no longer finds most industries, sectors, or even segments within sectors moving in-synch. The differences within each category and within each company will impact a portfolios performance more than it did just nine months ago.

The low and no cost of trading today all but eliminates the cost of commissions from things investors worry about. This cost was a big reason that investors moved to funds, to begin with. The other concern was expertise. As mentioned earlier, investors moved to funds in part to not have to rely on a broker and their research. Today, the internet has brought the cost of quality research down to approximately zero. Just logging on to your computer can put any level investor in touch with more information than any full-service broker ever had in 1980. It also can flood you with bad information and pseudo- research and even schemes to artificially pump stocks. Make sure you can trust where you’re getting your information from. Providers of quality research such as Morningstar,
Channelchek, or Standard &
Poor’s
are either partially or completely no cost to subscribers. These, along with information from an online broker, should be plenty for most self-directed investors or even advisors. Sites that promise the next hot stock should be viewed with caution.

Take Away

There are more investment vehicles, low-cost options of transacting, and choice than ever before. Investors that lazily place money in the overall market are not trying to enjoy the best possible returns. The bifurcated market of today is likely to continue. Sectors that will win are often being spelled out for us as we listen to how various stimulus packages are being created. Individual stocks can have extreme performance if they have a unique characteristic that puts their product or service in high demand in changing times. The various research companies offering top-tier information on equities is indispensable as you look for potential opportunity.

Suggested Reading:

Where
Investors Found Double-Digit Growth in Q1

There’s
Opportunity When Market Indexes are Adjusted

Michael
Burry Says Covid-19 Cure Worse that the Disease

 

Channelchek Community:

Unlimited, no cost subscription to company
research and premium features

Sources:
SPDR Sector Tracker

Research – E.W. Scripps Company (SSP) – Quarterly Preview: Riding Through The Storm

Monday, April 20, 2020

E.W. Scripps Company (SSP)

Quarterly Preview: Riding Through The Storm

The E.W. Scripps Co. (www.scripps.com) serves audiences and businesses through a growing portfolio of television, print and digital media brands. After approval of its acquisition of two Granite Broadcasting stations later this year, Scripps will own 21 local television stations as well as daily newspapers in 13 markets across the United States. It also runs an expanding collection of local and national digital journalism and information businesses including digital video news service Newsy. Scripps also produces television programming, runs an award-winning investigative reporting newsroom in Washington, D.C., and serves as the longtime steward of one of the nation�s largest, most successful and longest-running educational programs, Scripps National Spelling Bee. Founded in 1879, Scripps is focused on the stories of tomorrow.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Lowering price target due to CoVid impact. Due to lowered expectations for 2020, we are lowering our 12 to 18 month price target from $20 to $12. Our revised target reflects our original target multiple of 11.1 times based on our revised blended 2020/2021 cash flow estimates. We believe that the target price may be conservative should the company rationalize non core broadcast assets, as we expect.

    Lower 2020, posting 2021 estimates. We estimate that total company revenue will decrease 6% in Q2, increase 14.4% in Q3, and increase 26.9% in Q4 for total year 2020 revenue of $1.79 billion. These estimates reflect core advertising decline of 36% in Q2, offset by a substantial increase in Retrans revenue. Total company 2020 cash flow is estimated at $308.7 million. In this report, we are posting 2021 revenue of $1.74 billion and…


    Click here to get the full report.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Noble Capital Markets Analyst Profile – Naureen Quibria, Ph.D.

Naureen Quibria, Ph.D.

Senior Research Analyst, Life Sciences

Bio

Naureen Quibria, Ph.D. joined Noble Capital Markets as a Senior Research Analyst in December 2020. Prior to joining the firm, she was a Senior Biotechnology Analyst at Maxim Group. She began her career in equity research at H.C. Wainwright, followed by JMP Securities. She has also served in various consulting roles, including as Business Analyst at Johns Hopkins Technology Ventures. She has conducted research in academic labs at the NIH, Beth Israel Deaconess Medical Center/Harvard Medical School and UCLA. Dr. Quibria received her Ph.D. in Cell Biology and Pathology from Columbia University and holds a Bachelor’s degree in Biology from Bryn Mawr College.

Credentials

Senior Equity Research Analyst focusing on the Life Sciences sector. 5 years of industry experience. PhD in Cell Biology and Pathology from Columbia University. Bachelor’s degree in Biology from Bryn Mawr College. Post-Doctoral training at Columbia University and New York University. Conducted research in academic labs at the NIH, Beth Israel Deaconess Medical Center/Harvard Medical School and UCLA.

FINRA licenses 7, 63, 86, 87.

Coverage List

Research promis neurosciences inc- pmn ca advancing novel antibody therapeutics for neurodegenerative diseases

Monday, April 20, 2020

ProMIS Neurosciences Inc. (PMN:CA)

Advancing Novel Antibody Therapeutics for Neurodegenerative Diseases

ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for the treatment of neurodegenerative diseases, primarily Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform—ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody for AD; PMN350, a monoclonal antibody for AD; and PMN330, a monoclonal antibody targeting toxic prionlike forms of AßO for AD. The company is also developing prospect therapies targeting the neurotoxic form of the tau protein in AD; and superoxide dismutase 1 and TAR-DNA binding protein 43 in ALS and frontotemporal dementia, as well as alpha synuclein in Parkinson’s disease and Lewy body dementia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Cosme Ordonez, MD, Ph.D., Senior Life Sciences Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    ProMIS Neurosciences is developing novel antibody technologies. ProMIS has the capabilities to detect “Disease Associated Epitopes” on the surface of proteins, a technology with multiple applications in medicine. The Company is advancing programs for the treatment of Alzheimer’s disease, Parkinson’s disease and Amyotrophic lateral sclerosis (ALS).

    Development of antibody-based test for Covid-19. Recently, ProMIS announced a collaboration to develop a sensitive and specific laboratory test to detect antibodies against SARS-CoV-2, the virus causing Covid-19. Given ProMIS’ experience with peptide and antibody-based technologies, we believe the Company and its collaborators will be able to develop a specific test without cross-reactivity with other viruses in the coronavirus family. Thus far, high test specificity has been…



    Click here to get the full report.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.